36W-20057-29630
3 vaccinations
5 coded responses
33 check-ins
5 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 61-65
- ZIP prefix
- 220 / VA
- Registered
- 2021-03-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-13
Registered in v-safe
-
2021-03-13
Dose 1 — Pfizer-BioNTech
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-18
- 2021-03-19
- 2021-03-20
- 2021-03-27
-
2021-04-03
Dose 2 — Pfizer-BioNTech
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-10
- 2021-04-17
- 2021-04-24
- 2021-05-01
- 2021-05-08
- 2021-05-15
- 2021-07-03
-
2021-09-24
Dose 3 — Pfizer-BioNTech
- 2021-10-02
- 2021-10-03
-
2021-10-09
Survey response — day 14, dose 3MedDRA: Arthralgia — Feeling: GoodFree text: Joint painMedDRA releases: 2024-11 · check-in free text available
- 2021-10-15
-
2021-10-22
Survey response — day 28, dose 3MedDRA: Arthralgia — Feeling: GoodFree text: Aching joints but starting to improve.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-29
Survey response — day 35, dose 3MedDRA: Arthralgia, Rash — Feeling: GoodFree text: I have unexplained rashes under my arms and joint pain since my booster. They are not debilitating but annoying. Seem to be getting slowly better.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-05
Survey response — day 42, dose 3MedDRA: Arthralgia, Neuropathy peripheral, Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: My joints have stopped hurting but the neuropathy in my feet and calves is much worse.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-05
Report sent to call center — day 42, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-11-08
-
2021-11-09
Callback requested for05:00PM ET
-
2021-11-09
Call successfulParticipant prefers to complete VAERS report online
- 2021-12-26
- 2022-03-26
-
2022-09-24
Survey response — 12 months, dose 3MedDRA: Arthralgia, Arthritis — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, HospitalizationFree text: As mentioned in the past, the booster caused massive inflammation in all my joints. Over time, the inflammation went away except in my right hip, which will be replaced on Oct 5. I had no pain in that hip prior to the booster. I fully blame it.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-24
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Hospitalization · 1 call case(s)
-
2022-09-27
Call successfulReported to VAERS during previous contact from GDIT
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-13 | Pfizer-BioNTech | |
| 2 | 2021-04-03 | Pfizer-BioNTech | |
| 3 | 2021-09-24 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
VAERS report filed, before or during a call: 1
Free text
Release 10 — day 14, dose 3
Symptoms: Joint pain
Release 10 — day 28, dose 3
Symptoms: Aching joints but starting to improve.
Release 10 — day 35, dose 3
Symptoms: I have unexplained rashes under my arms and joint pain since my booster. They are not debilitating but annoying. Seem to be getting slowly better.
Release 10 — day 42, dose 3
Symptoms: My joints have stopped hurting but the neuropathy in my feet and calves is much worse.
Release 12 — 12 months, dose 3
Symptoms: As mentioned in the past, the booster caused massive inflammation in all my joints. Over time, the inflammation went away except in my right hip, which will be replaced on Oct 5. I had no pain in that hip prior to the booster. I fully blame it.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | · | · | ✓ |
| SD | Arthritis | · | · | ✓ |
| SD | Neuropathy peripheral | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Rash | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release